TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2026

Zolbetuximab plus chemotherapy in Japanese patients with claudin 18.2-positive gastric or gastroesophageal junction adenocarcinoma: a combined subgroup analysis of the phase 3 SPOTLIGHT and GLOW trials.

Kensei Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.